Proxy Votes Now

Home › Funds › Equitable › EQ/Franklin Small Cap Value Managed Volatility Portfolio

EQ/Franklin Small Cap Value Managed Volatility Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000013249

2023-20242024-20252025-2026

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 16,119 with, 56 against, 3 abstentions (not counted as with management); 5 items carried no recommendation; 19 split votes are in neither count. Shareholder proposals: 14 FOR, 26 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)94.4%15,59992.5%339,726
Backed environmental and social shareholder proposals at US companiesn/a79.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 717 items (4.7% of the 15,248 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Wyndham Hotels & Resorts, Inc.2026-05-14To vote on an advisory resolution to approve our executive compensation program.AgainstFOR — 12 of 12 Equitable fundsAgainstApproved, 85.1% support
Onto Innovation Inc.2026-05-20Election of Directors: David B. MillerAgainstFOR — 11 of 11 Equitable fundsAgainstPassed (calculated), 92.4% support
Oshkosh Corporation2026-05-05Shareholder To vote on a shareholder proposal on the subject of directors who fail to obtain a majority vote.ForAGAINST — 10 of 10 Equitable fundsAgainstFailed (calculated), 16.1% support
Vontier Corporation2026-06-04Election of Director: Gloria R. BoylandAgainstFOR — 9 of 9 Equitable fundsAgainstPassed (calculated), 95.4% support
Vontier Corporation2026-06-04Election of Director: Karen C. FrancisAgainstFOR — 9 of 9 Equitable fundsAgainstPassed (calculated), 95.5% support
Vontier Corporation2026-06-04Election of Director: Mark D. MorelliAgainstFOR — 9 of 9 Equitable fundsAgainstPassed (calculated), 95.5% support
Vontier Corporation2026-06-04Election of Director: Maryrose SylvesterAgainstFOR — 9 of 9 Equitable fundsAgainstPassed (calculated), 96.2% support
Vontier Corporation2026-06-04Election of Director: Robert L. EatroffAgainstFOR — 9 of 9 Equitable fundsAgainstPassed (calculated), 95.5% support
Knight-Swift Transportation Holdings Inc.2026-05-12Elect eleven directors, each such director to serve until the 2027 Annual Meeting: David Vander PloegAgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 89.2% support
Knight-Swift Transportation Holdings Inc.2026-05-12Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Kathryn MunroAgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 93.8% support
Knight-Swift Transportation Holdings Inc.2026-05-12Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Michael GarnreiterAgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 94.2% support
The Gap, Inc.2026-05-12Election of Directors: Robert J. FisherAgainstFOR — 8 of 8 Equitable fundsAgainstElected, 77.4% support
Fortune Brands Innovations, Inc.2026-05-05Advisory vote to approve named executive officer compensationAgainstFOR — 8 of 8 Equitable fundsAgainst—
Fortune Brands Innovations, Inc.2026-05-05Election of Class II Directors: A. D. David MackayAgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 79.2% support
Fortune Brands Innovations, Inc.2026-05-05Election of Class II Directors: Brendan M. FoleyAgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 90.2% support
Fortune Brands Innovations, Inc.2026-05-05Election of Class II Directors: Stephanie L. PuglieseAgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 81.7% support
Bruker Corporation2026-05-21Election of four Class II directors to serve for a three-year term expiring in 2028: Hermann F. Requardt, Ph.D.WithholdFOR — 7 of 7 Equitable fundsAgainstElected, 92.0% support
Valmont Industries, Inc.2026-04-27Election of Directors: Mogens C. BayWithholdFOR — 7 of 7 Equitable fundsAgainst—
Valmont Industries, Inc.2026-04-27Election of Directors: Ritu FavreWithholdFOR — 7 of 7 Equitable fundsAgainst—
Boyd Gaming Corporation2026-05-07Election of Directors: Christine J. SpadaforWithholdFOR — 7 of 7 Equitable fundsAgainstElected, 66.4% support
Boyd Gaming Corporation2026-05-07Election of Directors: Marianne Boyd JohnsonWithholdFOR — 7 of 7 Equitable fundsAgainstElected, 95.3% support
Boyd Gaming Corporation2026-05-07Election of Directors: William R. BoydWithholdFOR — 7 of 7 Equitable fundsAgainstElected, 92.6% support
Louisiana-Pacific Corporation2026-05-01Advisory vote to approve named executive officer compensationAgainstFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 89.2% support
Victory Capital Holdings, Inc.2026-05-06Election of Class II Directors: Mary JacksonAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 84.4% support
Select Water Solutions, Inc.2026-05-07To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Luis Fernandez-MorenoWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 80.7% support
Show the next 475
Items 26 to 500.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Select Water Solutions, Inc.2026-05-07To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Richard A. BurnettWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 76.0% support
Select Water Solutions, Inc.2026-05-07To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Robin H. FielderWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 80.7% support
WSFS Financial Corporation2026-05-14ELECTION OF DIRECTORS: David G. TurnerWithholdFOR — 4 of 4 Equitable fundsAgainstPassed (calculated), 89.2% support
First Commonwealth Financial Corporation2026-04-28Election of Directors: Jon L. GorneyAgainstFOR — 4 of 4 Equitable fundsAgainstElected, 92.2% support
First Commonwealth Financial Corporation2026-04-28Election of Directors: Ray T. CharleyAgainstFOR — 4 of 4 Equitable fundsAgainstElected, 89.5% support
BrightSpring Health Services, Inc.2026-05-21Election of Class II directors: Max LinWithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 76.3% support
Cracker Barrel Old Country Store, Inc.2025-11-20To elect ten (10) directors: Gilbert DavilaAgainstFOR — 3 of 3 Equitable fundsAgainst—
Cracker Barrel Old Country Store, Inc.2025-11-20To elect ten (10) directors: Jody BilneyAgainstFOR — 3 of 3 Equitable fundsAgainst—
Cracker Barrel Old Country Store, Inc.2025-11-20To elect ten (10) directors: Julie MasinoAgainstFOR — 3 of 3 Equitable fundsAgainst—
Ryerson Holding Corporation2026-04-30An amendment to our restated certificate of incorporation to provide for officer exculpation as permitted by Delaware Law.AgainstFOR — 3 of 3 Equitable fundsAgainstPassed (calculated), 85.4% support
Ryerson Holding Corporation2026-04-30The approval of the Third Amended and Restated Ryerson Holding Corporation 2014 Omnibus Incentive Plan.AgainstFOR — 3 of 3 Equitable fundsAgainstPassed (calculated), 68.2% support
First Bancorp2026-04-28Election of Directors: James C. Crawford, IIIWithholdFOR — 3 of 3 Equitable fundsAgainst—
Bloom Energy Corporation2026-05-21Election of our four Class II Directors: Eddy ZervigonForWITHHOLD — 4 of 5 Equitable fundsForElected, 76.8% support
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. ChouForWITHHOLD — 4 of 5 Equitable fundsForElected, 71.3% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Daniel HumeForWITHHOLD — 4 of 5 Equitable fundsForPassed (calculated), 78.6% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Yann EchelardForWITHHOLD — 4 of 5 Equitable fundsForPassed (calculated), 78.7% support
Protagonist Therapeutics, Inc.2026-06-17To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D.ForWITHHOLD — 4 of 5 Equitable fundsForPassed (calculated), 80.2% support
Arrowhead Pharmaceuticals, Inc.2026-03-19Election of Directors: Michael S. PerryAgainstFOR — 4 of 5 Equitable fundsAgainst—
Zeta Global Holdings Corp.2026-06-16Election of Directors: Jeanine SilberblattForWITHHOLD — 4 of 5 Equitable fundsForElected, 90.0% support
Zeta Global Holdings Corp.2026-06-16Election of Directors: Robert NiehausForWITHHOLD — 4 of 5 Equitable fundsForElected, 97.1% support
Zeta Global Holdings Corp.2026-06-16Election of Directors: William LandmanForWITHHOLD — 4 of 5 Equitable fundsForElected, 93.7% support
Axsome Therapeutics, Inc.2026-06-05Election of Directors: Mark SaadForWITHHOLD — 4 of 5 Equitable fundsForElected, 73.6% support
Axsome Therapeutics, Inc.2026-06-05Election of Directors: Susan Mahony, Ph.D., MBAForWITHHOLD — 4 of 5 Equitable fundsForElected, 76.7% support
CRISPR Therapeutics AG2026-06-04Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.ForAGAINST — 4 of 5 Equitable fundsFor—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.ForAGAINST — 4 of 5 Equitable fundsFor—
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the 2025 Compensation Report.ForAGAINST — 4 of 5 Equitable fundsFor—
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.ForAGAINST — 4 of 5 Equitable fundsForApproved, 69.4% support
CRISPR Therapeutics AG2026-06-04Re-election of Briggs W. Morrison, M.D.ForAGAINST — 4 of 5 Equitable fundsFor—
CRISPR Therapeutics AG2026-06-04Re-election of H. Edward Fleming, Jr., M.D.ForAGAINST — 4 of 5 Equitable fundsFor—
CRISPR Therapeutics AG2026-06-04Re-election of John T. GreeneForAGAINST — 4 of 5 Equitable fundsFor—
CRISPR Therapeutics AG2026-06-04Re-election of the members to the Board of Directors and the Chairman: Re-election of Samarth Kulkarni, Ph.D., as member and ChairmanForAGAINST — 4 of 5 Equitable fundsForElected, 96.7% support
Workiva Inc.2026-05-28Election of Directors: Michael M. Crow, Ph.D.ForWITHHOLD — 4 of 5 Equitable fundsForPassed (calculated), 77.9% support
Tenable Holdings, Inc.2026-05-13To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: A. Brooke SeawellForWITHHOLD — 4 of 5 Equitable fundsForElected, 74.7% support
Tenable Holdings, Inc.2026-05-13To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Raymond Vicks, Jr.ForWITHHOLD — 4 of 5 Equitable fundsForElected, 75.9% support
Appian Corporation2026-06-03Election of Directors: Carl Boe Hartman IIForWITHHOLD — 4 of 5 Equitable fundsForElected, 99.9% support
Appian Corporation2026-06-03Election of Directors: Mark LynchForWITHHOLD — 4 of 5 Equitable fundsForElected, 98.4% support
Appian Corporation2026-06-03Election of Directors: Matthew CalkinsForWITHHOLD — 4 of 5 Equitable fundsForElected, 98.2% support
Appian Corporation2026-06-03Election of Directors: Robert C. KramerForWITHHOLD — 4 of 5 Equitable fundsForElected, 98.3% support
Appian Corporation2026-06-03Election of Directors: Shirley A. EdwardsForWITHHOLD — 4 of 5 Equitable fundsForElected, 98.0% support
D-Wave Quantum Inc.2026-06-04Election of two Class I directors to hold office until our 2029 Annual Meeting of Stockholders: Sharon HoltForWITHHOLD — 4 of 5 Equitable fundsForPassed (calculated), 86.1% support
Intapp, Inc.2025-11-18To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Beverly AllenForWITHHOLD — 4 of 5 Equitable fundsForElected, 81.0% support
Intapp, Inc.2025-11-18To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Nancy HarrisForWITHHOLD — 4 of 5 Equitable fundsForElected, 95.2% support
Freshworks Inc.2026-05-28To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.ForAGAINST — 4 of 5 Equitable fundsForApproved, 86.9% support
Freshworks Inc.2026-05-28To elect the four nominees for Class II Directors, each to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Roxanne S. AustinForWITHHOLD — 4 of 5 Equitable fundsForElected, 91.3% support
Freshworks Inc.2026-05-28To elect the four nominees for Class II Directors, each to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Sameer GandhiForWITHHOLD — 4 of 5 Equitable fundsForElected, 93.1% support
SPS Commerce, Inc.2026-05-28Election of Directors: Michael McConnellForAGAINST — 4 of 5 Equitable fundsForElected, 78.6% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonForWITHHOLD — 4 of 5 Equitable fundsForElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingForWITHHOLD — 4 of 5 Equitable fundsForElected, 80.4% support
Grindr Inc.2026-06-02Election of Directors: Daniel Brooks BaerForWITHHOLD — 4 of 5 Equitable fundsForElected, 84.8% support
Grindr Inc.2026-06-02Election of Directors: G. Raymond Zage, IIIForWITHHOLD — 4 of 5 Equitable fundsForElected, 88.2% support
SoundHound AI, Inc.2026-05-22Election of Directors: Diana SrokaForWITHHOLD — 4 of 5 Equitable fundsForElected, 97.2% support
SoundHound AI, Inc.2026-05-22Election of Directors: Larry MarcusForWITHHOLD — 4 of 5 Equitable fundsForElected, 96.2% support
C3.ai, Inc.2025-10-03Election of Class II Directors: General (Ret.) John HytenForWITHHOLD — 4 of 5 Equitable fundsForElected, 97.9% support
C3.ai, Inc.2025-10-03Election of Class II Directors: Richard C. LevinForWITHHOLD — 4 of 5 Equitable fundsForElected, 98.0% support
Alkami Technology, Inc.2026-05-19To elect the three nominees for director named herein to serve as Class II directors to hold office until the 2029 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Brian R. SmithForWITHHOLD — 4 of 5 Equitable fundsForElected, 72.9% support
Ocular Therapeutix, Inc.2026-06-10To approve an advisory vote on named executive officer compensation.AgainstFOR — 4 of 5 Equitable fundsAgainst—
Telephone and Data Systems, Inc.2026-05-21Approval of an amendment to the Company's Restated Certificate of Incorporation to provide for exculpation of officersForABSTAIN or AGAINST — 4 of 5 Equitable fundsForApproved, 89.0% support
Madrigal Pharmaceuticals, Inc.2026-06-172 wordings Re-election of Class I directors: Julian BakerForWITHHOLD — 5 of 7 Equitable fundsForElected, 88.6% support
FirstCash Holdings, Inc.2026-06-09Approve the reincorporation of the Company to the State of Texas by conversion.ForAGAINST — 5 of 7 Equitable fundsForApproved, 58.4% support
FirstCash Holdings, Inc.2026-06-09Election of Directors: Randel G. OwenForAGAINST — 5 of 7 Equitable fundsForPassed (calculated), 87.7% support
Rambus Inc.2026-04-23Election of Directors: Charles KissnerForAGAINST — 5 of 7 Equitable fundsForPassed (calculated), 85.5% support
Rambus Inc.2026-04-23Election of Directors: Luc SeraphinForAGAINST — 5 of 7 Equitable fundsForPassed (calculated), 98.5% support
Rambus Inc.2026-04-23Election of Directors: Meera RaoForAGAINST — 5 of 7 Equitable fundsForPassed (calculated), 93.9% support
Rambus Inc.2026-04-23Election of Directors: Necip SayinerForAGAINST — 5 of 7 Equitable fundsForPassed (calculated), 93.5% support
Silicon Laboratories Inc.2026-04-23To elect two Class I directors to serve on the Board of Directors until our 2029 annual meeting of stockholders, or until a successor is duly elected and qualified: Navdeep S. SoochForAGAINST — 5 of 7 Equitable fundsForPassed (calculated), 97.6% support
Silicon Laboratories Inc.2026-04-23To elect two Class I directors to serve on the Board of Directors until our 2029 annual meeting of stockholders, or until a successor is duly elected and qualified: Nina RichardsonForAGAINST — 5 of 7 Equitable fundsForPassed (calculated), 98.5% support
Rhythm Pharmaceuticals, Inc.2026-06-24Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirrForWITHHOLD — 5 of 7 Equitable fundsForPassed (calculated), 85.9% support
Qualys, Inc.2026-06-10Election of Directors: John A. ZangardiForWITHHOLD — 5 of 7 Equitable fundsForElected, 94.5% support
Qualys, Inc.2026-06-10Election of Directors: Wendy M. PfeifferForWITHHOLD — 5 of 7 Equitable fundsForElected, 91.4% support
DigitalOcean Holdings, Inc.2026-06-15Election of Class II Directors: Warren AdelmanForWITHHOLD — 5 of 8 Equitable fundsForPassed (calculated), 79.8% support
Cytokinetics, Incorporated2026-05-273 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.ForWITHHOLD — 5 of 8 Equitable fundsForPassed (calculated), 97.0% support
GPGI, Inc.2026-06-11Election of Directors: Brian F. HughesWithholdFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 97.8% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Ian ClarkForWITHHOLD — 4 of 6 Equitable fundsForElected, 65.0% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Manuel Hidalgo MedinaForWITHHOLD — 4 of 6 Equitable fundsForElected, 75.5% support
Glaukos Corporation2026-05-28Election of Directors: Aimee S. WeisnerForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 95.0% support
Glaukos Corporation2026-05-28Election of Directors: Denice M. TorresForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 78.5% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: David A. DunbarForWITHHOLD — 4 of 6 Equitable fundsForElected, 90.0% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Joseph T. NoonanForWITHHOLD — 4 of 6 Equitable fundsForElected, 99.1% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Joseph W. ReitmeierForWITHHOLD — 4 of 6 Equitable fundsForElected, 90.1% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Kenneth NapolitanoForWITHHOLD — 4 of 6 Equitable fundsForElected, 90.3% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Merilee RainesForWITHHOLD — 4 of 6 Equitable fundsForElected, 89.9% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Michael J. DuboseForWITHHOLD — 4 of 6 Equitable fundsForElected, 86.1% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Rebecca J. BollForWITHHOLD — 4 of 6 Equitable fundsForElected, 90.3% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Robert J. Pagano, Jr.ForWITHHOLD — 4 of 6 Equitable fundsForElected, 97.9% support
Globalstar, Inc.2026-05-13Approve, on an advisory basis, the compensation of our named executive officers.ForAGAINST — 3 of 4 Equitable fundsForApproved, 96.4% support
Globalstar, Inc.2026-05-13Election of Class B Directors: Timothy E. TaylorForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 95.4% support
Twist Bioscience Corporation2026-02-05Election of Class II Directors: Jan JohannessenForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 84.1% support
Twist Bioscience Corporation2026-02-05Election of Class II Directors: Keith CrandellForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 80.5% support
Twist Bioscience Corporation2026-02-05To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."ForAGAINST — 3 of 4 Equitable fundsForApproved, 76.4% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioForAGAINST — 4 of 6 Equitable fundsForPassed (calculated), 86.6% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarForWITHHOLD — 3 of 4 Equitable fundsForElected, 96.4% support
Sanmina Corporation2026-03-09To elect eight directors of Sanmina Corporation: Mythili SankaranForAGAINST — 4 of 6 Equitable fundsForPassed (calculated), 56.9% support
MSA Safety Incorporated2026-05-08Election of Directors for a term expiring in 2029: Nishan J. VartanianForWITHHOLD — 4 of 6 Equitable fundsForElected, 93.2% support
StoneX Group Inc.2026-03-10Election of Directors: Steven KassForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 97.2% support
Xometry, Inc.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Fabio RosatiForWITHHOLD — 3 of 4 Equitable fundsForElected, 90.0% support
Xometry, Inc.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Katharine WeymouthForWITHHOLD — 3 of 4 Equitable fundsForElected, 86.7% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciForWITHHOLD — 4 of 6 Equitable fundsForElected, 85.3% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyForWITHHOLD — 4 of 6 Equitable fundsForElected, 86.8% support
IES Holdings, Inc.2026-02-19ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.AgainstFOR — 3 of 4 Equitable fundsAgainstApproved, 92.8% support
IES Holdings, Inc.2026-02-19ELECTION OF DIRECTORS: TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING AND UNTIL THEIR SUCCESSORS ARE ELECTED AND QUALIFIED: JOE D. KOSHKINWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 96.6% support
IES Holdings, Inc.2026-02-19ELECTION OF DIRECTORS: TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING AND UNTIL THEIR SUCCESSORS ARE ELECTED AND QUALIFIED: TODD M. CLEVELANDWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 97.2% support
Dycom Industries Inc.2026-05-28Election of Directors: Peter T. Pruitt, Jr.ForAGAINST — 4 of 6 Equitable fundsForPassed (calculated), 96.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Andrea PerezForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Andrew DudumForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 99.1% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Anja ManuelForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Christopher PayneForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 99.4% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: David WellsForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 98.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Deb AutorForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Delos Cosgrove, M.D.ForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Kare SchultzForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 99.9% support
Braze, Inc.2026-06-302 wordings Election of Two Class II Directors, each to hold office until our 2029 Annual Meeting of Stockholders: Neeraj AgrawalForWITHHOLD — 3 of 4 Equitable fundsForElected, 78.6% support
StepStone Group Inc.2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Michael I. McCabeForWITHHOLD — 3 of 4 Equitable fundsForElected, 91.4% support
StepStone Group Inc.2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Monte M. BremWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 85.9% support
StepStone Group Inc.2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Steven R. MitchellForWITHHOLD — 3 of 4 Equitable fundsForElected, 90.8% support
BGC Group, Inc.2025-11-12Approval, on an advisory basis, of executive compensation.ForAGAINST — 3 of 4 Equitable fundsForApproved, 93.6% support
BGC Group, Inc.2025-11-12Election of Directors: Arthur U. MbanefoForWITHHOLD — 3 of 4 Equitable fundsForElected, 92.5% support
BGC Group, Inc.2025-11-12Election of Directors: David P. RichardsForWITHHOLD — 3 of 4 Equitable fundsForElected, 94.5% support
BGC Group, Inc.2025-11-12Election of Directors: Linda A. BellForWITHHOLD — 3 of 4 Equitable fundsForElected, 94.2% support
BGC Group, Inc.2025-11-12Election of Directors: William D. AddasForWITHHOLD — 3 of 4 Equitable fundsForElected, 94.7% support
Modine Manufacturing Company2025-08-21Election of Directors: Mr. David J. WilsonForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 91.6% support
Acushnet Holdings Corp.2026-06-08Election of the following nominees for director: Yoon Soo (Gene) YoonWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 82.6% support
Remitly Global, Inc.2026-06-10Election of Directors: Bora ChungForWITHHOLD — 3 of 4 Equitable fundsForElected, 96.0% support
Remitly Global, Inc.2026-06-10Election of Directors: Laurent Le MoalForWITHHOLD — 3 of 4 Equitable fundsForElected, 96.3% support
Remitly Global, Inc.2026-06-10Election of Directors: Nigel MorrisForWITHHOLD — 3 of 4 Equitable fundsForElected, 68.9% support
Moelis & Company2026-06-25Election of Directors: Eric CantorForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 97.8% support
Moelis & Company2026-06-25Election of Directors: Kenneth L. ShropshireForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 87.9% support
Moelis & Company2026-06-25Election of Directors: Kenneth MoelisForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 98.3% support
Moelis & Company2026-06-25Election of Directors: Laila J. WorrellForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 85.0% support
Moelis & Company2026-06-25Election of f Directors: Louise MirrerForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 84.0% support
Moelis & Company2026-06-25To approve, on an advisory basis, the compensation of our Named Executive Officers.ForAGAINST — 3 of 4 Equitable fundsForApproved, 76.5% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Aylwin LewisAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 73.2% support
The Chefs' Warehouse, Inc.2026-05-08To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement.AgainstFOR — 3 of 4 Equitable fundsAgainstApproved, 51.0% support
Construction Partners, Inc.2026-03-24Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Craig JenningsForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 79.8% support
Interparfums, Inc.2025-09-10To vote for the advisory resolution to approve executive compensation.ForAGAINST — 3 of 4 Equitable fundsForApproved, 84.3% support
CorVel Corporation2025-08-07To approve the 2025 Stock Incentive Plan.ForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 84.0% support
CorVel Corporation2025-08-07To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Jeffrey J. MichaelWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 84.4% support
CorVel Corporation2025-08-07To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: R. Judd JessupWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 87.6% support
Edgewise Therapeutics, Inc.2026-06-04Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Badreddin Edris, Ph.D.WithholdFOR — 3 of 4 Equitable fundsAgainstElected, 70.3% support
Franklin Electric Co., Inc.2026-05-082 wordings Elect Victor D. Grizzle and Alok Maskara as directors for terms expiring at the 2029 Annual Meeting of Shareholders: Victor D. GrizzleForAGAINST — 3 of 4 Equitable fundsFor—
Boot Barn Holdings, Inc.2025-08-27Election of Directors: Lisa G. LaubeWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 78.3% support
SL Green Realty Corp.2026-06-02Election of Directors: Andrew W. MathiasForAGAINST — 3 of 4 Equitable fundsForElected, 90.8% support
SL Green Realty Corp.2026-06-02Election of Directors: Carol N. BrownForAGAINST — 3 of 4 Equitable fundsForElected, 99.0% support
SL Green Realty Corp.2026-06-02Election of Directors: Craig M. HatkoffForAGAINST — 3 of 4 Equitable fundsForElected, 91.7% support
SL Green Realty Corp.2026-06-02Election of Directors: John H. AlschulerForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 90.5% support
SL Green Realty Corp.2026-06-02Election of Directors: Lauren B. DillardForAGAINST — 3 of 4 Equitable fundsForElected, 94.3% support
SL Green Realty Corp.2026-06-02Election of Directors: Peggy LambForAGAINST — 3 of 4 Equitable fundsForElected, 92.3% support
SL Green Realty Corp.2026-06-02Election of Directors: Stephen L. GreenForAGAINST — 3 of 4 Equitable fundsForElected, 95.8% support
SL Green Realty Corp.2026-06-02To approve, on a non-binding advisory basis, our executive compensation.ForAGAINST — 3 of 4 Equitable fundsForApproved, 70.3% support
Acadia Pharmaceuticals Inc.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu, Pharm.D., J.D.ForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 89.4% support
Acadia Pharmaceuticals Inc.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. DalyForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 97.7% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Donna M. ColemanForWITHHOLD — 3 of 4 Equitable fundsForElected, 79.5% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Frederic V. SalernoForWITHHOLD — 3 of 4 Equitable fundsForElected, 79.6% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Martin BandierForWITHHOLD — 3 of 4 Equitable fundsForElected, 79.4% support
AvePoint, Inc.2026-05-05Election of Directors: Brian Michael BrownForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 91.6% support
AvePoint, Inc.2026-05-05Election of Directors: Jeff EpsteinForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 76.8% support
AvePoint, Inc.2026-05-05Election of Directors: John HoForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 94.9% support
Diodes Incorporated2026-05-11To elect six persons to the Board of Directors of the Company, each to serve until the next annual meeting of stockholders and until their respective successors have been elected and qualified: Huey-Jen (Jenny) SuForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 89.8% support
Cal-Maine Foods, Inc.2025-10-03Election of Class I Directors: Camille S. YoungForWITHHOLD — 3 of 4 Equitable fundsFor—
Shake Shack Inc.2026-06-10Election of Directors- Terms expiring at the 2029 Annual Meeting of Stockholders: Tristan WalkerForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 74.9% support
Century Aluminum Company2026-06-15Election of Directors: Andrew MichelmoreForWITHHOLD — 3 of 4 Equitable fundsForElected, 91.8% support
Century Aluminum Company2026-06-15Election of Directors: Errol GlasserForWITHHOLD — 3 of 4 Equitable fundsForElected, 89.0% support
Century Aluminum Company2026-06-15Election of Directors: Jarl BerntzenForWITHHOLD — 3 of 4 Equitable fundsForElected, 91.4% support
Century Aluminum Company2026-06-15Election of Directors: Jennifer BushForWITHHOLD — 3 of 4 Equitable fundsForElected, 91.6% support
Century Aluminum Company2026-06-15Election of Directors: Tamla OlivierForWITHHOLD — 3 of 4 Equitable fundsForElected, 91.6% support
Century Aluminum Company2026-06-15Election of Directors: Wilhelm van JaarsveldForWITHHOLD — 3 of 4 Equitable fundsForElected, 99.2% support
ADMA Biologics, Inc.2026-06-02To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. FingerForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 89.0% support
ADMA Biologics, Inc.2026-06-02To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene SalasForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 97.6% support
Vertex, Inc.2026-06-10Election of directors: David DeStefanoForWITHHOLD — 3 of 4 Equitable fundsForElected, 99.6% support
Vertex, Inc.2026-06-10Election of directors: Eric AndersenForWITHHOLD — 3 of 4 Equitable fundsForElected, 97.2% support
Cipher Digital Inc.2026-06-02Approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 3 of 4 Equitable fundsForApproved, 83.5% support
NetScout Systems, Inc.2025-09-10Election of Directors: To elect four Class II Directors nominated by our Board of Directors, and named in the accompanying Proxy Statement, each to serve for a three-year term and until their successors are duly elected and qualified: John R. EganForWITHHOLD — 3 of 4 Equitable fundsForElected, 81.9% support
NetScout Systems, Inc.2025-09-10Election of Directors: To elect four Class II Directors nominated by our Board of Directors, and named in the accompanying Proxy Statement, each to serve for a three-year term and until their successors are duly elected and qualified: Marlene PelageForWITHHOLD — 3 of 4 Equitable fundsForElected, 99.5% support
NetScout Systems, Inc.2025-09-10Election of Directors: To elect four Class II Directors nominated by our Board of Directors, and named in the accompanying Proxy Statement, each to serve for a three-year term and until their successors are duly elected and qualified: Robert E. DonahueForWITHHOLD — 3 of 4 Equitable fundsForElected, 89.9% support
NetScout Systems, Inc.2025-09-10To approve the NetScout Systems, Inc. 2019 Equity Incentive Plan, as amended.ForAGAINST — 3 of 4 Equitable fundsForApproved, 76.3% support
MARA Holdings, Inc.2026-06-18A non-binding, advisory vote on the compensation of our Named Executive Officers ("Say-on-Pay").ForAGAINST — 3 of 4 Equitable fundsForApproved, 59.1% support
MARA Holdings, Inc.2026-06-18Election of Class III directors to serve until our 2029 annual meeting of stockholders: Vicki Mealer-BurkeWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 59.2% support
Upstart Holdings, Inc.2026-05-28Election of Directors: Ciaran O'KellyForWITHHOLD — 3 of 4 Equitable fundsForElected, 86.9% support
Upstart Holdings, Inc.2026-05-28Election of Directors: Kerry CooperForWITHHOLD — 3 of 4 Equitable fundsForElected, 97.5% support
Upstart Holdings, Inc.2026-05-28Election of Directors: Mary HentgesForWITHHOLD — 3 of 4 Equitable fundsForElected, 98.4% support
Recursion Pharmaceuticals, Inc.2026-06-17Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement.ForAGAINST — 3 of 4 Equitable fundsForApproved, 87.0% support
Recursion Pharmaceuticals, Inc.2026-06-17Election of Directors: Franziska Michor, Ph.D.ForWITHHOLD — 3 of 4 Equitable fundsForElected, 87.3% support
Calix, Inc.2026-05-14To elect each of the three director nominees named in the proxy statement: Kathleen CruscoForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 90.7% support
BioCryst Pharmaceuticals, Inc.2026-06-11To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan.ForAGAINST or ABSTAIN — 4 of 6 Equitable fundsForApproved, 65.4% support
Astrana Health, Inc.2026-06-10To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: David G. SchmidtForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 93.7% support
Harmony Biosciences Holdings, Inc.2026-05-14Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules.ForAGAINST — 3 of 4 Equitable fundsForApproved, 71.8% support
Harmony Biosciences Holdings, Inc.2026-05-14The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron PhilipForWITHHOLD — 3 of 4 Equitable fundsForElected, 68.5% support
Harmony Biosciences Holdings, Inc.2026-05-14The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy IgnelziWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 70.6% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: David HodgsonForWITHHOLD — 3 of 4 Equitable fundsForElected, 60.8% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jacqueline KosecoffForWITHHOLD — 3 of 4 Equitable fundsForElected, 76.1% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jody BilneyForWITHHOLD — 3 of 4 Equitable fundsForElected, 76.1% support
NovoCure Limited2026-06-03The approval of our amended and restated 2024 Omnibus Incentive Plan.ForAGAINST — 3 of 4 Equitable fundsForApproved, 50.3% support
Innovative Industrial Properties, Inc.2026-06-09Approval on a non-binding advisory basis of the compensation of the Company's named executive officers.ForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 63.9% support
Innovative Industrial Properties, Inc.2026-06-09Election of directors, each to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: David BoyleForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 90.3% support
Cracker Barrel Old Country Store, Inc.2025-11-20To ratify, on an advisory basis, the inclusion of the Ineligibility Provision in the Company's bylaws.AgainstFOR — 3 of 4 Equitable fundsAgainst—
Cracker Barrel Old Country Store, Inc.2025-11-20To ratify, on an advisory basis, the inclusion of the Mutual Reimbursement Provision in the Company's bylaws.AgainstFOR — 3 of 4 Equitable fundsAgainst—
American Assets Trust, Inc.2026-06-01Election of Directors: Dr. Robert S. SullivanForWITHHOLD — 3 of 4 Equitable fundsForElected, 76.3% support
American Assets Trust, Inc.2026-06-01Election of Directors: Ernest S. RadyForWITHHOLD — 3 of 4 Equitable fundsForElected, 96.3% support
American Assets Trust, Inc.2026-06-01Election of Directors: Joy L. SchaeferForWITHHOLD — 3 of 4 Equitable fundsForElected, 62.7% support
American Assets Trust, Inc.2026-06-01Election of Directors: Thomas S. OlingerForWITHHOLD — 3 of 4 Equitable fundsForElected, 97.2% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Angela D. Pruitt-MarriottForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 96.2% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Jeffrey A. CarusForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 95.2% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Kenneth K. Quigley, Jr.ForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 96.0% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Matthew I. HirschForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 59.1% support
Quantum Computing Inc.2026-06-24Elect six directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Dr. Carl WeimerWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 82.9% support
Quantum Computing Inc.2026-06-24Elect six directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Robert FagensonWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 90.6% support
Easterly Government Properties, Inc.2026-04-22Approval of the Easterly Government Properties, Inc. 2024 Equity Incentive Plan Amendment.ForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 78.1% support
Easterly Government Properties, Inc.2026-04-22Approval, on a non-binding advisory basis, of our named executive officer compensation.ForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 92.9% support
Coursera, Inc.2026-06-10The election of three Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Andrew Y. NgForWITHHOLD — 3 of 4 Equitable fundsForElected, 86.1% support
Coursera, Inc.2026-06-10The election of three Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Christopher D. McCarthyForWITHHOLD — 3 of 4 Equitable fundsForElected, 84.4% support
JBG SMITH Properties2026-04-30To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement ("Say-on-Pay").ForAGAINST — 3 of 4 Equitable fundsFor—
N-able, Inc.2026-05-28Election of Class II Directors: Darryl LewisForWITHHOLD — 3 of 4 Equitable fundsForElected, 96.7% support
N-able, Inc.2026-05-28Election of Class II Directors: James Cameron McMartinForWITHHOLD — 3 of 4 Equitable fundsForElected, 87.8% support
N-able, Inc.2026-05-28Election of Class II Directors: Michael BingleForWITHHOLD — 3 of 4 Equitable fundsForElected, 85.0% support
Eos Energy Enterprises, Inc.2026-06-03Amendment to our Second Amended and Restated 2020 Incentive Plan.ForAGAINST — 3 of 4 Equitable fundsForApproved, 74.8% support
Eos Energy Enterprises, Inc.2026-06-03Election of Directors: Claude DembyForAGAINST — 3 of 4 Equitable fundsForPassed (calculated), 76.7% support
Eos Energy Enterprises, Inc.2026-06-03Non-binding advisory vote to approve our named executive officer compensation.ForAGAINST — 3 of 4 Equitable fundsForApproved, 75.3% support
eXp World Holdings, Inc.2026-05-08Election of Directors to serve for a one-year term expiring in 2027. Randall MilesAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 88.9% support
Cogent Communications Holdings, Inc.2026-05-01To hold an advisory vote to approve named executive officer compensation.ForAGAINST — 3 of 4 Equitable fundsFor—
Elme Communities2025-10-30Adjournment Proposal: To approve one or more adjournments of the Special Meeting, solely with respect to the proposals for which insufficient votes to approve such proposals were cast, to a later date or dates, if necessary, appropriate or advisable to solicit additional proxies.ForABSTAIN — 3 of 4 Equitable fundsFor—
Elme Communities2025-10-30Liquidation Proposal: To approve the Plan of Sale and Liquidation of the Company (the "Plan of Sale and Liquidation") providing for the sale or disposition of all the Company's assets (whether or not the Portfolio Sale Proposal is approved or the Portfolio Sale Transaction closes), winding down the ForABSTAIN — 3 of 4 Equitable fundsFor—
Elme Communities2025-10-30Portfolio Sale Proposal: To approve the sale of 19 multifamily properties of Elme Communities (the "Company") to an affiliate of Cortland Partners, LLC ("Cortland"), subject to and in accordance with the terms of the Purchase and Sale Agreement (the "Purchase Agreement"), dated as of August 1, 2025,ForABSTAIN — 3 of 4 Equitable fundsFor—
Jamf Holding Corp.2026-01-08A proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"), dated as of October 28, 2025, by and among Jamf, Jawbreaker Parent, Inc., a Delaware corporation ("Parent"), and Jawbreaker Merger Sub, Inc., a DForABSTAIN — 3 of 4 Equitable fundsForApproved, 99.8% support
LiveRamp Holdings, Inc.2025-08-12Election of Directors: Brian O'KelleyForAGAINST — 3 of 4 Equitable fundsForElected, 95.6% support
LiveRamp Holdings, Inc.2025-08-12Election of Directors: Clark M. KokichForAGAINST — 3 of 4 Equitable fundsForElected, 92.3% support
Moog Inc.2026-02-10Election of directors: Class A Director - Term Expiring 2029: Brenda ReichelderferForWITHHOLD — 3 of 4 Equitable fundsForElected, 95.0% support
StoneCo Ltd.2026-04-23Accept Financial Statements and Statutory ReportsAbstainFOR — 3 of 4 Equitable fundsAgainst—
StoneCo Ltd.2026-04-23Elect Director Antonio SilveiraForAGAINST — 3 of 4 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Diego Fresco GutierrezForAGAINST — 3 of 4 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Gilberto CaldartForAGAINST — 3 of 4 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Jose Alexandre ScheinkmanForAGAINST — 3 of 4 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Luciana Ibiapina Lira AguiarForAGAINST — 3 of 4 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Luis Henrique Cals de Beauclair GuimaraesForAGAINST — 3 of 4 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Mauricio Luis LuchettiForAGAINST — 3 of 4 Equitable fundsFor—
Veris Residential, Inc.2026-05-21To approve the transactions contemplated by that certain Agreement and Plan of Merger, dated as of February 23, 2026 (as the same may be amended, modified or supplemented from time to time in accordance with its terms, the "Merger Agreement"), by and among Veris Residential, Inc., a Maryland corporaForABSTAIN — 3 of 4 Equitable fundsForApproved, 100.0% support
ICU Medical, Inc.2026-05-13Shareholder To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right.AgainstFOR — 5 of 9 Equitable fundsForNot approved, 40.7% support
Nextracker Inc.2025-08-18The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Brandi ThomasForWITHHOLD — 4 of 7 Equitable fundsForElected, 96.5% support
Nextracker Inc.2025-08-18The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey GuldnerForWITHHOLD — 4 of 7 Equitable fundsForElected, 74.3% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 97.3% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 95.0% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 80.1% support
Kymera Therapeutics, Inc.2026-06-24To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFAForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 93.6% support
Hecla Mining Company2026-05-21ELECTION OF TWO CLASS I DIRECTORS: Dean R. GehringForAGAINST — 4 of 7 Equitable fundsForElected, 96.3% support
Knight-Swift Transportation Holdings Inc.2026-05-12Shareholder Vote on a stockholder proposal regarding support for transparency in political spending.AgainstFOR — 4 of 7 Equitable fundsForNot approved, 39.5% support
Granite Construction Incorporated2026-06-04Election of Directors: Carlos M. HernandezForAGAINST — 4 of 7 Equitable fundsForPassed (calculated), 96.1% support
Granite Construction Incorporated2026-06-04Election of Directors: Celeste B. MastinForAGAINST — 4 of 7 Equitable fundsForPassed (calculated), 94.6% support
EnerSys2025-07-31Elect three (3) Class III director nominees: Howard I. HoffenForAGAINST — 4 of 7 Equitable fundsForElected, 86.9% support
EnerSys2025-07-31Elect three (3) Class III director nominees: Ronald P. VargoForAGAINST — 4 of 7 Equitable fundsForElected, 96.4% support
Itron, Inc.2026-05-07Election of Directors: Frank M. JaehnertForAGAINST — 4 of 7 Equitable fundsForElected, 83.7% support
Itron, Inc.2026-05-07Election of Directors: Jerome J. LandeForAGAINST — 4 of 7 Equitable fundsForElected, 96.0% support
Itron, Inc.2026-05-07Election of Directors: Sanjay MirchandaniForAGAINST — 4 of 7 Equitable fundsForElected, 96.5% support
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Che-Wei LinForWITHHOLD — 4 of 7 Equitable fundsFor—
Applied Optoelectronics, Inc.2026-06-04To approve the 2026 equity incentive plan.ForAGAINST — 4 of 7 Equitable fundsForPassed (calculated), 90.2% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.ForWITHHOLD — 4 of 7 Equitable fundsForElected, 73.5% support
Nuvalent, Inc.2026-06-16Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D.ForWITHHOLD — 4 of 7 Equitable fundsForElected, 81.5% support
PotlatchDeltic Corporation2026-01-27The PotlatchDeltic merger-related compensation proposal: A proposal to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of PotlatchDeltic in connection with the transactions contemplated by the merger agreement.ForAGAINST — 4 of 7 Equitable fundsForNot approved, 28.5% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Laurence CharneyForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 83.7% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Michael S. WeissForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 88.6% support
PACS Group, Inc.2026-06-10To elect Evelyn Dilsaver and Mark Hancock as Class II directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Evelyn DilsaverForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 95.0% support
Crocs, Inc.2026-06-09Election of Directors: Beth J. KaplanForWITHHOLD — 3 of 5 Equitable fundsForElected, 96.7% support
Crocs, Inc.2026-06-09Election of Directors: Neeraj S. TolmareForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.4% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: Paul MeisterForAGAINST — 3 of 5 Equitable fundsForElected, 87.5% support
Southwest Gas Holdings, Inc.2026-05-07Election of directors: Carlos A. RuisanchezForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 99.1% support
Black Hills Corporation2026-04-02To vote on a proposal to amend the Black Hills Charter to change the name of Black Hills (the "Black Hills Name Change Amendment");ForABSTAIN — 3 of 5 Equitable fundsFor—
Black Hills Corporation2026-04-02To vote on a proposal to amend the restated articles of incorporation of Black Hills (the "Black Hills Charter") to increase the authorized shares from 100 million to 300 million (the "Black Hills Share Increase Proposal");ForABSTAIN — 3 of 5 Equitable fundsForApproved, 91.5% support
Black Hills Corporation2026-04-02To vote on a proposal to approve any motion to adjourn the Black Hills special meeting, if necessary (the "Black Hills Meeting Adjournment Proposal").ForABSTAIN — 3 of 5 Equitable fundsForApproved, 91.6% support
Black Hills Corporation2026-04-02To vote on a proposal to approve the issuance of shares of common stock, par value $1.00 per share, of Black Hills ("Black Hills Common Stock"), pursuant to the terms of the Agreement and Plan of Merger, dated as of August 18, 2025 (the "Merger Agreement"), by and among Black Hills, River Merger SubForABSTAIN — 3 of 5 Equitable fundsFor—
Black Hills Corporation2026-04-02To vote on a proposal to increase the authorized indebtedness of Black Hills from $8 billion to $20 billion (the "Black Hills Indebtedness Increase Proposal");ForABSTAIN — 3 of 5 Equitable fundsForPassed (calculated), 98.9% support
Black Hills Corporation2026-04-02To vote on an advisory vote on the merger-related compensation arrangements of Black Hills' named executive officers (the "Black Hills Merger-Related Compensation Proposal"); andForABSTAIN — 3 of 5 Equitable fundsFor—
Black Hills Corporation2026-04-29Election of Directors: Anne G. WaleskiForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 98.8% support
Black Hills Corporation2026-04-29Election of Directors: Scott M. ProchazkaForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 96.1% support
Black Hills Corporation2026-04-29Election of Directors: Teresa A. TaylorForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.9% support
Casella Waste Systems, Inc.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Emily Nagle GreenForWITHHOLD — 3 of 5 Equitable fundsForElected, 66.5% support
Casella Waste Systems, Inc.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Joseph G. DoodyForWITHHOLD — 3 of 5 Equitable fundsForElected, 89.9% support
Casella Waste Systems, Inc.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Michael L. BattlesForWITHHOLD — 3 of 5 Equitable fundsForElected, 73.4% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Andrew T. D'AmicoForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.3% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Claudio TuozzoloForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.3% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: James F. SchmidtForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.1% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jason L. CarlsonForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 93.7% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: John ShenForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.7% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Michael S. McNamaraForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.3% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Patrizio VinciarelliForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.0% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Philip D. DaviesForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.5% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Samuel J. AndersonForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.4% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Zmira LavieForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.7% support
Essent Group Ltd.2026-05-06ELECTION OF DIRECTORS: Douglas J. Pauls Class III DirectorForWITHHOLD — 3 of 5 Equitable fundsFor—
Essent Group Ltd.2026-05-06ELECTION OF DIRECTORS: Mark Casale Class III DirectorForWITHHOLD — 3 of 5 Equitable fundsFor—
Essent Group Ltd.2026-05-06ELECTION OF DIRECTORS: William Spiegel Class III DirectorForWITHHOLD — 3 of 5 Equitable fundsFor—
RadNet, Inc.2026-06-02Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Laura P. JacobsForWITHHOLD — 3 of 5 Equitable fundsForElected, 87.4% support
Terex Corporation2026-01-28Proposal to approve the adjournment of the Terex special meeting to solicit additional proxies if there are not sufficient votes at the time of the Terex special meeting to approve the Terex stock issuance proposal (the "Terex adjournment proposal").ForABSTAIN — 3 of 5 Equitable fundsFor—
Terex Corporation2026-01-28Proposal to approve the issuance of shares of Terex common stock to holders of REV common stock pursuant to the Merger Agreement (the "Terex stock issuance proposal"); andForABSTAIN — 3 of 5 Equitable fundsForApproved, 95.6% support
Hancock Whitney Corporation2026-04-29Election of Directors: C. Richard WilkinsForWITHHOLD — 3 of 5 Equitable fundsForElected, 98.2% support
Hancock Whitney Corporation2026-04-29Election of Directors: Constantine S. LiollioForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.4% support
Hancock Whitney Corporation2026-04-29Election of Directors: Frank E. BertucciForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.4% support
Hancock Whitney Corporation2026-04-29Election of Directors: Joan C. TeofiloForWITHHOLD — 3 of 5 Equitable fundsForElected, 98.2% support
Hancock Whitney Corporation2026-04-29Election of Directors: Thomas H. OlindeForWITHHOLD — 3 of 5 Equitable fundsForElected, 95.7% support
Balchem Corporation2026-06-18Election of Directors: Daniel KnutsonForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 98.4% support
Balchem Corporation2026-06-18Election of Directors: David FischerForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 93.1% support
Varonis Systems, Inc.2026-06-01To elect four Class III director nominees named herein to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Avrohom J. KessForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 91.1% support
Varonis Systems, Inc.2026-06-01To elect four Class III director nominees named herein to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Thomas F. MendozaForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.4% support
Waystar Holding Corp.2026-06-01Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: John DriscollForWITHHOLD — 3 of 5 Equitable fundsForElected, 86.5% support
Louisiana-Pacific Corporation2026-05-01Election of Class II Directors: Jean-Michel RibierasForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 88.9% support
Louisiana-Pacific Corporation2026-05-01Election of Class II Directors: Jose A. BayardoForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 89.1% support
Concentra Group Holdings Parent, Inc.2026-04-30Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. WatkinsForAGAINST — 3 of 5 Equitable fundsForElected, 81.8% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term)ForAGAINST — 3 of 5 Equitable fundsForElected, 97.6% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term)ForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 97.8% support
Axos Financial, Inc.2025-11-13Election of Directors: James J. CourtForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 62.4% support
Axos Financial, Inc.2025-11-13Election of Directors: James S. ArgalasForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 95.7% support
Axos Financial, Inc.2025-11-13Election of Directors: Roque A. SantiForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 97.1% support
Axos Financial, Inc.2025-11-13Election of Directors: Stefani D. CarterForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 62.8% support
Axos Financial, Inc.2025-11-13To approve an amendment to the Amended and Restated 2014 Stock Incentive Plan.ForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 63.1% support
Axos Financial, Inc.2025-11-13To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in the proxy statement.ForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 58.7% support
Travere Therapeutics, Inc.2026-05-19To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Roy BaynesWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 87.7% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Ellyn ShookForWITHHOLD — 3 of 5 Equitable fundsForElected, 82.2% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Lowry BaldwinForWITHHOLD — 3 of 5 Equitable fundsForElected, 95.7% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sathish MuthukrishnanForWITHHOLD — 3 of 5 Equitable fundsForElected, 99.0% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sunita ParasuramanForWITHHOLD — 3 of 5 Equitable fundsForElected, 98.9% support
First Advantage Corporation2026-06-05To elect three Class II director nominees listed in this Proxy Statement: Bridgett R. PriceForWITHHOLD — 3 of 5 Equitable fundsForElected, 93.7% support
BancFirst Corporation2026-05-28Election of Directors: David R. HarlowForAGAINST — 3 of 5 Equitable fundsForElected, 85.0% support
Cohen & Steers, Inc.2026-04-30Election of Directors: Edmond D. VillaniAgainstFOR — 3 of 5 Equitable fundsAgainstPassed (calculated), 87.9% support
Relay Therapeutics, Inc.2026-06-09To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Claire Mazumdar, Ph.D.ForWITHHOLD — 3 of 5 Equitable fundsForElected, 83.5% support
Relay Therapeutics, Inc.2026-06-09To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. IngramForWITHHOLD — 3 of 5 Equitable fundsForElected, 82.2% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Denise Knouse-SnyderForWITHHOLD — 3 of 5 Equitable fundsForElected, 94.4% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: F. Eric Nelson, Jr.ForWITHHOLD — 3 of 5 Equitable fundsForElected, 91.3% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: John L. BookmyerForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.6% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Louis M. AltmanForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.6% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Todd F. ClossinForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.2% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (b) For a term of one (1) year expiring at the annual stockholders meeting in 2027: Joseph R. RobinsonForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.7% support
Polaris Inc.2026-04-30Adoption of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive PlanForAGAINST — 3 of 5 Equitable fundsForApproved, 85.2% support
Polaris Inc.2026-04-30The election of three Class II directors for three-year terms ending 2029: Gary E. HendricksonForAGAINST — 3 of 5 Equitable fundsForElected, 89.9% support
Polaris Inc.2026-04-30The election of three Class II directors for three-year terms ending 2029: George W. BilicicForAGAINST — 3 of 5 Equitable fundsForElected, 89.8% support
Polaris Inc.2026-04-30The election of three Class II directors for three-year terms ending 2029: Gwenne A. HenricksForAGAINST — 3 of 5 Equitable fundsForElected, 94.9% support
Core Scientific, Inc.2026-05-12Election of Directors: Elizabeth CrainForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.7% support
Core Scientific, Inc.2026-05-12To approve, on a non-binding, advisory basis, the compensation of our named executive officers.ForAGAINST — 3 of 5 Equitable fundsForApproved, 63.7% support
Oceaneering International, Inc.2026-05-15Election of Class I Directors: Jon Erik ReinhardsenForWITHHOLD — 3 of 5 Equitable fundsForElected, 81.0% support
Oceaneering International, Inc.2026-05-15Election of Class I Directors: Reema PoddarForWITHHOLD — 3 of 5 Equitable fundsForElected, 91.8% support
Oceaneering International, Inc.2026-05-15Election of Class I Directors: William B. BerryForWITHHOLD — 3 of 5 Equitable fundsForElected, 96.9% support
Celcuity Inc.2026-05-14To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan.AgainstFOR — 3 of 5 Equitable fundsAgainst—
OSI Systems, Inc.2025-12-11Election of Directors: William F. BallhausForAGAINST — 3 of 5 Equitable fundsForElected, 82.6% support
Worthington Enterprises, Inc.2025-09-23Approve the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors.ForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 91.7% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Billy R. VickersForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 96.1% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: David P. BlomForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 90.4% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Kerrii B. AndersonForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 97.7% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Paul G. HellerForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 99.5% support
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: Alan F. HarrisForWITHHOLD — 3 of 5 Equitable fundsForElected, 92.1% support
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: Barbara L. BraiserForWITHHOLD — 3 of 5 Equitable fundsFor—
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: David A. CiesinskiForWITHHOLD — 3 of 5 Equitable fundsForElected, 99.1% support
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: Elliot K. FullenForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.6% support
F&G Annuities & Life, Inc.2026-06-24Election of three Class I directors to serve until the 2029 annual meeting of shareholders: J. Douglas MartinezForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 98.5% support
F&G Annuities & Life, Inc.2026-06-24Election of three Class I directors to serve until the 2029 annual meeting of shareholders: John D. RoodForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 92.2% support
Axcelis Technologies, Inc.2026-02-06To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Axcelis Share Issuance Proposal.ForABSTAIN — 3 of 5 Equitable fundsFor—
Axcelis Technologies, Inc.2026-02-06To approve the issuance of shares of Axcelis Technologies, Inc. ("Axcelis") common stock (the "Axcelis Share Issuance Proposal") pursuant to the Agreement and Plan of Merger, dated as of September 30, 2025, by and among Axcelis, Victory Merger Sub, Inc., a wholly owned subsidiary of Axcelis, and VeeForABSTAIN — 3 of 5 Equitable fundsFor—
Axcelis Technologies, Inc.2026-05-05Election of Directors: Jeanne QuirkForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 88.2% support
Beam Therapeutics Inc.2026-06-03Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi ShawForAGAINST — 3 of 5 Equitable fundsForElected, 90.5% support
Beam Therapeutics Inc.2026-06-03Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John EvansForAGAINST — 3 of 5 Equitable fundsForElected, 98.8% support
Beam Therapeutics Inc.2026-06-03Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D.ForAGAINST — 3 of 5 Equitable fundsForElected, 89.4% support
Flywire Corporation2026-06-02Elect three directors to serve as Class II directors until the 2029 Annual Meeting of Stockholders: Alex FinkelsteinForWITHHOLD — 3 of 5 Equitable fundsForElected, 70.3% support
Flywire Corporation2026-06-02Elect three directors to serve as Class II directors until the 2029 Annual Meeting of Stockholders: Gretchen HowardForWITHHOLD — 3 of 5 Equitable fundsForElected, 74.1% support
Flywire Corporation2026-06-02Elect three directors to serve as Class II directors until the 2029 Annual Meeting of Stockholders: Matthew HarrisForWITHHOLD — 3 of 5 Equitable fundsForElected, 73.4% support
Asana, Inc.2026-06-08Election of three Class III directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sydney CareyForWITHHOLD — 3 of 5 Equitable fundsForElected, 93.6% support
Arcus Biosciences, Inc.2026-06-11Election of Directors: David Lacey, M.D.ForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 82.4% support
Arcus Biosciences, Inc.2026-06-11Election of Directors: Dietmar Berger, M.D., Ph.D.ForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 82.4% support
Arcus Biosciences, Inc.2026-06-11Election of Directors: Johanna MercierForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 82.4% support
Arcus Biosciences, Inc.2026-06-11Election of Directors: Nicole LambertForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 88.8% support
Cipher Digital Inc.2026-06-02Election of Directors: James NewsomeForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.3% support
Cipher Digital Inc.2026-06-02Election of Directors: Wesley WilliamsForWITHHOLD — 3 of 5 Equitable fundsForElected, 84.9% support
Fastly, Inc.2026-06-03To elect each of the Board's three nominees for director named in the accompanying proxy statement, to serve as a Class I member of the Board of Directors until the 2029 annual meeting of stockholders: Aida AlvarezForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 65.1% support
Fastly, Inc.2026-06-03To elect each of the Board's three nominees for director named in the accompanying proxy statement, to serve as a Class I member of the Board of Directors until the 2029 annual meeting of stockholders: Richard DanielsForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.7% support
TransMedics Group, Inc.2026-05-20Election of Directors: Edward M. BasileForAGAINST — 3 of 5 Equitable fundsForElected, 93.1% support
TransMedics Group, Inc.2026-05-20Election of Directors: Edwin M. Kania, Jr.ForAGAINST — 3 of 5 Equitable fundsForElected, 98.2% support
TransMedics Group, Inc.2026-05-20Election of Directors: Merilee RainesForAGAINST — 3 of 5 Equitable fundsForElected, 99.4% support
TransMedics Group, Inc.2026-05-20Election of Directors: Thomas J. GundersonForAGAINST — 3 of 5 Equitable fundsForElected, 98.4% support
TransMedics Group, Inc.2026-05-20To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan byForAGAINST — 3 of 5 Equitable fundsForApproved, 71.9% support
Addus HomeCare Corporation2026-06-10Election of Directors: Michael EarleyForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 91.5% support
Addus HomeCare Corporation2026-06-10Election of Directors: Veronica Hill-MilbourneForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 96.9% support
Vera Therapeutics, Inc.2026-05-21To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Michael M. Morrissey, Ph.D.ForWITHHOLD — 3 of 5 Equitable fundsForElected, 76.6% support
Vera Therapeutics, Inc.2026-05-21To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Patrick G. EnrightForWITHHOLD — 3 of 5 Equitable fundsForElected, 92.5% support
Goosehead Insurance, Inc.2026-05-04Election of Directors: Robyn JonesForWITHHOLD — 3 of 5 Equitable fundsForElected, 77.3% support
Goosehead Insurance, Inc.2026-05-04Election of Directors: William Wade, Jr.ForWITHHOLD — 3 of 5 Equitable fundsForElected, 77.3% support
Diebold Nixdorf, Incorporated2026-05-22Election of Directors: Arthur F. AntonForABSTAIN — 3 of 5 Equitable fundsForPassed (calculated), 98.4% support
Diebold Nixdorf, Incorporated2026-05-22Election of Directors: Dr. Colin J. ParrisForABSTAIN — 3 of 5 Equitable fundsForPassed (calculated), 98.5% support
Diebold Nixdorf, Incorporated2026-05-22Election of Directors: Mark GrossForABSTAIN — 3 of 5 Equitable fundsForPassed (calculated), 94.0% support
Diebold Nixdorf, Incorporated2026-05-22Election of Directors: Matthew J. EspeForABSTAIN — 3 of 5 Equitable fundsForPassed (calculated), 98.5% support
BioCryst Pharmaceuticals, Inc.2026-06-11Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Amy E. Mckee, M.D.ForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.3% support
BioCryst Pharmaceuticals, Inc.2026-06-11Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Jon P. StonehouseForWITHHOLD — 3 of 5 Equitable fundsForElected, 94.6% support
BioCryst Pharmaceuticals, Inc.2026-06-11Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Theresa M. HeggieForWITHHOLD — 3 of 5 Equitable fundsForElected, 96.2% support
Marqeta, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 78.5% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) LiForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 92.2% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha CummingsForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 82.1% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma AtkinsonForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 87.8% support
Novavax, Inc.2026-06-18Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D.ForAGAINST — 3 of 5 Equitable fundsForElected, 58.6% support
Novavax, Inc.2026-06-18Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. RodgersForAGAINST — 3 of 5 Equitable fundsForElected, 60.4% support
Novavax, Inc.2026-06-18The approval, on an advisory basis, of the compensation of our Named Executive Officers.ForAGAINST — 3 of 5 Equitable fundsForApproved, 50.7% support
Arlo Technologies, Inc.2026-06-18Election of three Class II directors for three-year terms: Amy RothsteinForWITHHOLD — 3 of 5 Equitable fundsForElected, 81.0% support
Arlo Technologies, Inc.2026-06-18Election of three Class II directors for three-year terms: Grady K. SummersForWITHHOLD — 3 of 5 Equitable fundsForElected, 95.8% support
Arlo Technologies, Inc.2026-06-18Election of three Class II directors for three-year terms: Prashant (Sean) AggarwalForWITHHOLD — 3 of 5 Equitable fundsForElected, 80.8% support
Ocular Therapeutix, Inc.2026-06-10To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Merilee RainesForWITHHOLD — 3 of 5 Equitable fundsForElected, 86.9% support
8x8, Inc.2025-07-25To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares.ForAGAINST — 3 of 5 Equitable fundsForApproved, 62.2% support
Rocket Pharmaceuticals, Inc.2026-05-20The approval of the proposed stock option exchange program; andForAGAINST — 3 of 5 Equitable fundsForApproved, 72.1% support
Rocket Pharmaceuticals, Inc.2026-05-20The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. SouthwellForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 68.2% support
Akero Therapeutics, Inc.2025-12-02To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger.ForAGAINST — 3 of 5 Equitable fundsForApproved, 98.0% support
Amicus Therapeutics, Inc.2026-03-03To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger.ForAGAINST — 3 of 5 Equitable fundsForApproved, 89.6% support
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren DeardorfForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 75.7% support
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S.ForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 74.5% support
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D.ForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 93.0% support
First BanCorp.2026-05-06Election of Directors: Roberto R. HerenciaForAGAINST — 3 of 5 Equitable fundsFor—
Graham Holdings Company2026-05-05Election of Directors: Christopher C. DavisForAGAINST — 3 of 5 Equitable fundsFor—
Graham Holdings Company2026-05-05Election of Directors: Danielle ConleyForAGAINST — 3 of 5 Equitable fundsFor—
Graham Holdings Company2026-05-05Election of Directors: Tony AllenForAGAINST — 3 of 5 Equitable fundsFor—
Jamf Holding Corp.2026-01-08A proposal to adjourn the special meeting (the "Special Meeting") of stockholders of Jamf to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.ForABSTAIN — 3 of 5 Equitable fundsFor—
Kestra Medical Technologies, Ltd.2025-09-03The approval of the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan.AgainstFOR — 3 of 5 Equitable fundsAgainst—
Verint Systems Inc.2025-11-18Approval, on a non-binding, advisory basis, of certain compensation that may be paid or become payable to Verint's named executive officers in connection with the Merger.ForAGAINST — 3 of 5 Equitable fundsFor—
Veris Residential, Inc.2026-05-21To adjourn the special meeting to a later date or time if necessary or appropriate to ensure that any necessary supplement or amendment to the accompanying proxy statement is provided to Company stockholders a reasonable amount of time in advance of the special meeting or to solicit additional proxiForABSTAIN — 3 of 5 Equitable fundsFor—
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: J. Kristofer GalashanForWITHHOLD — 2 of 3 Equitable fundsForElected, 76.4% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Jennifer PomerantzForWITHHOLD — 2 of 3 Equitable fundsForElected, 77.4% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Joel AlsfineForWITHHOLD — 2 of 3 Equitable fundsForElected, 94.8% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Jonathan CosletForWITHHOLD — 2 of 3 Equitable fundsForElected, 79.6% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Stuart LasherForWITHHOLD — 2 of 3 Equitable fundsForElected, 89.4% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander PlouffeForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 99.5% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Laura LangForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 99.9% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha SankaranForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 99.7% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Vanessa Ames WittmanForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 99.8% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 96.9% support
ViaSat, Inc.2025-09-04Election of Directors: Richard BaldridgeForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 93.9% support
ViaSat, Inc.2025-09-04Election of Directors: Sean PakForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 83.6% support
SM Energy Company2026-01-27to vote on a proposal to approve an amendment of SM Energy's restated certificate of incorporation (the "SM Energy charter amendment") to increase the number of authorized shares of SM Energy common stock from 200 million to 400 million, in the form attached to the accompanying joint proxy statementForABSTAIN — 2 of 3 Equitable fundsForApproved, 99.0% support
SM Energy Company2026-01-27to vote on a proposal to approve the issuance of shares of SM Energy's common stock, par value $0.01 per share ("SM Energy common stock"), to stockholders of Civitas Resources, Inc. ("Civitas") in the first merger contemplated by the Agreement and Plan of Merger, dated as of November 2, 2025, by andForABSTAIN — 2 of 3 Equitable fundsForApproved, 99.5% support
PJT Partners Inc.2026-06-18To elect the three nominees for Class II directors listed below, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders (Proposal 1): K. Don CornwellForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 97.8% support
PJT Partners Inc.2026-06-18To elect the three nominees for Class II directors listed below, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders (Proposal 1): Thomas M. RyanForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 84.6% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Angela CourtinForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 76.3% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Manuel A. DiazForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 99.5% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Mark CarletonForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 99.7% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Michael J. DominguezForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 98.7% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Nicolas BrienForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 99.6% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Peter MathesForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 98.7% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Susan M. TolsonForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 66.4% support
SSR Mining Inc.2026-05-07Election of Directors: Karen SwagerWithholdFOR — 2 of 3 Equitable fundsAgainstElected, 83.5% support
SSR Mining Inc.2026-05-07Election of Directors: Thomas R. Bates, Jr.WithholdFOR — 2 of 3 Equitable fundsAgainstElected, 61.6% support
SSR Mining Inc.2026-05-07To approve on an advisory (non-binding) basis, the compensation of the Company's named executive officers disclosed in this Proxy Statement.AgainstFOR — 2 of 3 Equitable fundsAgainstPassed (calculated), 54.3% support
Hut 8 Corp.2026-06-11To elect eight directors to serve until our 2027 Annual Meeting of Stockholders: Mayo A. Shattuck IIIAgainstFOR — 2 of 3 Equitable fundsAgainstElected, 89.6% support
Joby Aviation, Inc.2026-06-02Election of Directors: To be elected for terms expiring in 2029: Halimah DeLaine PradoForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 92.9% support
Joby Aviation, Inc.2026-06-02Election of Directors: To be elected for terms expiring in 2029: Laura WrightForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 98.4% support
Joby Aviation, Inc.2026-06-02Election of Directors: To be elected for terms expiring in 2029: Paul SciarraForWITHHOLD — 2 of 3 Equitable fundsForPassed (calculated), 98.9% support
Cavco Industries, Inc.2025-07-29Election of Directors: David A. GreenblattForAGAINST — 2 of 3 Equitable fundsForElected, 89.9% support
Cavco Industries, Inc.2025-07-29Election of Directors: Julia W. SzeForAGAINST — 2 of 3 Equitable fundsForElected, 97.1% support
Cavco Industries, Inc.2025-07-29Election of Directors: Richard A. KerleyForAGAINST — 2 of 3 Equitable fundsForElected, 95.6% support
Perimeter Solutions, Inc.2026-05-28To elect as directors the eight nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2027 Annual Meeting of Stockholders, or until their respective successors are elected and qualified: Robert S. HendersonForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 85.2% support
Perimeter Solutions, Inc.2026-05-28To elect as directors the eight nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2027 Annual Meeting of Stockholders, or until their respective successors are elected and qualified: Sean HennessyForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 88.4% support
Perimeter Solutions, Inc.2026-05-28To elect as directors the eight nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2027 Annual Meeting of Stockholders, or until their respective successors are elected and qualified: Tracy Britt CoolForAGAINST — 2 of 3 Equitable fundsForPassed (calculated), 59.3% support
Perimeter Solutions, Inc.2026-05-28To elect as directors the eight nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2027 Annual Meeting of Stockholders, or until their respective successors are elected and qualified: W. Nicholas HowleyAgainstFOR — 2 of 3 Equitable fundsAgainstPassed (calculated), 89.0% support
Perimeter Solutions, Inc.2026-05-28To elect as directors the eight nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2027 Annual Meeting of Stockholders, or until their respective successors are elected and qualified: William N. Thorndike, Jr.AgainstFOR — 2 of 3 Equitable fundsAgainstPassed (calculated), 90.8% support
Cinemark Holdings, Inc.2026-05-144 wordings Election of Class I directors, each for a term that expires in 2029: Nancy LoeweForWITHHOLD — 2 of 3 Equitable fundsForElected, 94.3% support
Nelnet, Inc.2026-05-14Election of three Class III directors for three-year terms: David S. GraffForAGAINST — 2 of 3 Equitable fundsForElected, 99.5% support
Nelnet, Inc.2026-05-14Election of three Class III directors for three-year terms: Kathleen A. FarrellForAGAINST — 2 of 3 Equitable fundsForElected, 96.7% support
Nelnet, Inc.2026-05-14Election of three Class III directors for three-year terms: Thomas E. HenningForAGAINST — 2 of 3 Equitable fundsForElected, 99.7% support
UniFirst Corporation2025-12-15Shareholder To elect two Class II Directors, each to serve for a term of three years until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Arnaud AjdlerWithholdFOR — 2 of 3 Equitable fundsForNot elected, 68.5% support
UniFirst Corporation2025-12-15To elect two Class II Directors, each to serve for a term of three years until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Steven S. SintrosForWITHHOLD — 2 of 3 Equitable fundsForElected, 27.2% support
UniFirst Corporation2026-06-11To adopt the Agreement and Plan of Merger (as it may be amended from time to time), by and among UniFirst Corporation ("UniFirst"), Cintas Corporation ("Cintas"), Bruin Merger Sub I, Inc. ("Merger Sub Inc."), and Bruin Merger Sub II, LLC ("Merger Sub LLC"), dated as of March 10, 2026, pursuant to whForABSTAIN — 2 of 3 Equitable fundsForApproved, 100.0% support
Golar LNG Limited2026-05-19Elect Director Benoit de la FouchardiereAgainstFOR — 2 of 3 Equitable fundsAgainst—
Golar LNG Limited2026-05-19Elect Director Tor Olav TroimAgainstFOR — 2 of 3 Equitable fundsAgainst—
Scorpio Tankers Inc.2026-05-27Elect Director Emanuele A. LauroForWITHHOLD — 2 of 3 Equitable fundsFor—
Scorpio Tankers Inc.2026-05-27Elect Director Niccolo CameranaForWITHHOLD — 2 of 3 Equitable fundsFor—
CVR Energy, Inc.2026-06-04To approve, on an advisory basis, our named executive officer compensation.ForAGAINST — 2 of 3 Equitable fundsForApproved, 91.6% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Brett IcahnForWITHHOLD — 2 of 3 Equitable fundsForElected, 92.6% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Colin KwakForWITHHOLD — 2 of 3 Equitable fundsForElected, 86.1% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: David L. LampForWITHHOLD — 2 of 3 Equitable fundsForElected, 92.6% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Dustin DeMariaForWITHHOLD — 2 of 3 Equitable fundsForElected, 86.1% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Stephen MongilloWithholdFOR — 2 of 3 Equitable fundsAgainstElected, 88.3% support
Excelerate Energy, Inc.2026-06-04To elect the seven director nominees named in the proxy statement as directors of the Company, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Nisha D. BiswaForWITHHOLD — 2 of 3 Equitable fundsForElected, 92.7% support
Excelerate Energy, Inc.2026-06-04To elect the seven director nominees named in the proxy statement as directors of the Company, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Tyler D. ToddForWITHHOLD — 2 of 3 Equitable fundsForElected, 92.0% support
Magnite, Inc.2026-06-08Election of Class III Directors: David PearsonForAGAINST — 2 of 3 Equitable fundsForElected, 95.3% support
Magnite, Inc.2026-06-08Election of Class III Directors: Doug KnopperForAGAINST — 2 of 3 Equitable fundsForElected, 92.8% support
Magnite, Inc.2026-06-08Election of Class III Directors: Paul CaineForAGAINST — 2 of 3 Equitable fundsForElected, 95.0% support
Independent Bank Corp.2026-05-14Election of Class III Directors: Daniel F. O'BrienForAGAINST — 2 of 3 Equitable fundsForElected, 92.1% support
Independent Bank Corp.2026-05-14Election of Class III Directors: James O. MortonForAGAINST — 2 of 3 Equitable fundsForElected, 92.8% support
Independent Bank Corp.2026-05-14Election of Class III Directors: Leif O'LearyForAGAINST — 2 of 3 Equitable fundsForElected, 95.1% support

217 more in the CSV.

Download all 717 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 89.4% of this fund’s 16,178 such votes could be given a sector; the other 1,714 (10.6%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance3,23330.1%
Consumer Discretionary2,801230.8%
Health Care2,452110.4%
Industrials1,71470.4%
Technology1,43240.3%
Real Estate89610.1%
Energy61600.0%
Utilities39600.0%
Consumer Staples25552.0%
Basic Materials25400.0%
Miscellaneous21000.0%
Telecommunications20510.5%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections10,91123
Audit-related1,9010
Say-on-Pay1,8812
Compensation6660
Corporate Governance48217
Capital Structure2693
Extraordinary Transactions2113
Shareholder Rights and Defenses511
Other110
Other Social Issues81

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
ACI Worldwide, Inc.June 2, 2026$6M110
CNO Financial Group, Inc.May 12, 2026$5M110
WSFS Financial CorporationMay 14, 2026$4M50
Columbia Banking System, Inc.July 21, 2025$4M20
Avient CorporationMay 14, 2026$4M130
Vontier CorporationJune 4, 2026$4M90
Columbia Banking System, Inc.May 14, 2026$4M140
Benchmark Electronics, Inc.May 28, 2026$4M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalForAgainst
May 12, 2026Knight-Swift Transportation Holdings Inc.Vote on a stockholder proposal regarding support for transparency in political spending. Shareholder proposalAgainstFor
May 5, 2026Oshkosh CorporationTo vote on a shareholder proposal on the subject of directors who fail to obtain a majority vote. Shareholder proposalForAgainst
May 14, 2026Wyndham Hotels & Resorts, Inc.To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder proposalForAgainst
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
May 4, 2026Asbury Automotive Group, Inc.Stockholder proposal regarding special stockholder meetings. Shareholder proposalAgainstFor
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalAgainstFor
December 15, 2025UniFirst CorporationTo elect two Class II Directors, each to serve for a term of three years until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposalWithholdFor
December 15, 2025UniFirst CorporationTo elect two Class II Directors, each to serve for a term of three years until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposalForAgainst
May 5, 2026SkyWest, Inc.A shareholder proposal regarding collective bargaining policy. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.

Funds that vote the same way

These funds reported the same votes as EQ/Franklin Small Cap Value Managed Volatility Portfolio in the latest season (or all but a few items), so they share this page:

Search this fund’s votes by company

16,399 ballot items at 2,109 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, EQ/Franklin Small Cap Value Managed Volatility Portfolio voted at 2,109 shareholder meetings of 1,985 companies, on 16,399 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 56 times. Its most frequent area of disagreement was director elections (23 of its votes against management). It voted on 61 shareholder proposals. It voted FOR the board's own proposals more often than Equitable's funds as a whole (94.4% against 92.5%). It voted differently from most Equitable funds on 717 items. 13 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.